SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001140361-20-011896
Filing Date
2020-05-19
Accepted
2020-05-19 06:05:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 POS AM nt10011952x2_posam.htm POS AM 556470
2 EXHIBIT 23.1 nt10011952x2_ex23-1.htm EX-23.1 2035
3 logo_myovantsciences.jpg GRAPHIC 50637
  Complete submission text file 0001140361-20-011896.txt   629113
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: POS AM | Act: 33 | File No.: 333-231764 | Film No.: 20891533
SIC: 2834 Pharmaceutical Preparations